InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

CEL SCI CORP

CVM Clue Score42
United States Fiscal year ends September CIK 0000725363
$1.94 -0.51% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.94 −81.29% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2017Operating income−21.4Net income−14.4EPS, diluted−1.91Fiscal year 2018Operating income−16.8Net income−31.8EPS, diluted−1.87Fiscal year 2019Operating income−20.2Net income−22.1EPS, diluted−0.71Fiscal year 2020Operating income−29.0Net income−30.3EPS, diluted−0.82Fiscal year 2021Operating income−36.2Net income−36.4EPS, diluted−0.90Fiscal year 2022Operating income−36.1Net income−36.7EPS, diluted−0.87Fiscal year 2023Operating income−31.5Net income−32.4EPS, diluted−0.73Fiscal year 2024Operating income−26.4Net income−26.9EPS, diluted−15.31Fiscal year 2025Operating income−24.8Net income−25.4EPS, diluted−6.27
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating income −21.4 −16.8 −20.2 −29.0 −36.2 −36.1 −31.5 −26.4 −24.8
Net income −14.4 −31.8 −22.1 −30.3 −36.4 −36.7 −32.4 −26.9 −25.4
Growth
EPS, diluted −1.91 −1.87 −0.71 −0.82 −0.90 −0.87 −0.73 −15.31 −6.27

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−13.8Capital expenditure−0.0Free cash flow−13.8Fiscal year 2018Operating cash flow−13.4Capital expenditure−0.0Free cash flow−13.4Fiscal year 2019Operating cash flow−16.3Capital expenditure0.2Free cash flow−16.1Fiscal year 2020Operating cash flow−15.3Capital expenditure−2.7Free cash flow−17.9Fiscal year 2021Operating cash flow−18.8Capital expenditure−9.0Free cash flow−27.8Fiscal year 2022Operating cash flow−18.2Capital expenditure−0.6Free cash flow−18.9Fiscal year 2023Operating cash flow−22.8Capital expenditure−0.4Free cash flow−23.2Fiscal year 2024Operating cash flow−18.8Capital expenditure−0.1Free cash flow−18.9Fiscal year 2025Operating cash flow−17.1Capital expenditure−0.0Free cash flow−17.2
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −13.8 −13.4 −16.3 −15.3 −18.8 −18.2 −22.8 −18.8 −17.1
Capital expenditure −0.0 −0.0 0.2 −2.7 −9.0 −0.6 −0.4 −0.1 −0.0
Free cash flow −13.8 −13.4 −16.1 −17.9 −27.8 −18.9 −23.2 −18.9 −17.2
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2017Cash2.4Shareholders’ equity−3.3Fiscal year 2018Cash10.3Shareholders’ equity0.0Fiscal year 2019Cash8.4Shareholders’ equity5.1Fiscal year 2020Cash15.5Shareholders’ equity19.7Fiscal year 2021Cash36.1Shareholders’ equity56.5Fiscal year 2022Cash22.7Shareholders’ equity32.2Fiscal year 2023Cash4.1Shareholders’ equity13.2Fiscal year 2024Cash4.7Shareholders’ equity12.9Fiscal year 2025Cash11.0Shareholders’ equity16.0
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 2.4 10.3 8.4 15.5 36.1 22.7 4.1 4.7 11.0
Shareholders’ equity −3.3 0.0 5.1 19.7 56.5 32.2 13.2 12.9 16.0

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending September, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 30 Sep 2017 FY2018 30 Sep 2018 FY2019 30 Sep 2019 FY2020 30 Sep 2020 FY2021 30 Sep 2021 FY2022 30 Sep 2022 FY2023 30 Sep 2023 FY2024 30 Sep 2024 FY2025 30 Sep 2025
Returns
n/a −3,475,677.4% −431.2% −153.4% −64.3% −114.1% −244.9% −209.2% −159.2%
−62.7% −107.6% −80.1% −74.6% −47.9% −72.6% −106.0% −99.7% −90.3%
Balance and payout
114.6% 100.0% 81.4% 51.3% 25.5% 36.3% 56.7% 52.3% 43.3%